Paul T McIntosh1, Lisa D Hobson-Webb2, Zoheb B Kazi1, Sean N Prater1, Suhrad G Banugaria1, Stephanie Austin1, Raymond Wang3, David S Enterline4, Donald P Frush5, Priya S Kishnani6. 1. Department of Pediatrics, Division of Medical Genetics, Duke University, Durham, NC, USA. 2. Department of Neurology, Neuromuscular Division, Duke University, Durham, NC, USA. 3. Department of Metabolic Disorders, Children's Hospital of Orange County, Orange, CA, USA. 4. Department of Radiology, Division of Neuroradiology, Duke University, Durham, NC, USA. 5. Department of Radiology, Division of Pediatric Radiology, Duke University, Durham, NC, USA. 6. Department of Pediatrics, Division of Medical Genetics, Duke University, Durham, NC, USA. Electronic address: Priya.kishnani@duke.edu.
Abstract
BACKGROUND: Recombinant human acid α-glucosidase (rhGAA) enzyme replacement therapy (ERT) has prolonged survival in infantile Pompe disease (IPD), but has unmasked central nervous system (CNS) changes. METHODS: Brain imaging, consisting of computed tomography (CT) and/or magnetic resonance imaging (MRI), was performed on 23 patients with IPD (17 CRIM-positive, 6 CRIM-negative) aged 2-38months. Most patients had baseline neuroimaging performed prior to the initiation of ERT. Follow-up neuroimaging was performed in eight. RESULTS: Sixteen patients (70%) had neuroimaging abnormalities consisting of ventricular enlargement (VE) and/or extra-axial cerebrospinal fluid accumulation (EACSF) at baseline, with delayed myelination in two. Follow-up neuroimaging (n=8) after 6-153months showed marked improvement, with normalization of VE and EACSF in seven patients. Two of three patients imaged after age 10years demonstrated white matter changes, with one noted to have a basilar artery aneurysm. CONCLUSIONS: Mild abnormalities on brain imaging in untreated or newly treated patients with IPD tend to resolve with time, in conjunction with ERT. However, white matter changes are emerging as seen in Patients 1 and 3 which included abnormal periventricular white matter changes with subtle signal abnormalities in the basal ganglia and minimal, symmetric signal abnormalities involving the deep frontoparietal cerebral white matter, respectively. The role of neuroimaging as part of the clinical evaluation of IPD needs to be considered to assess for white matter changes and cerebral aneurysms.
BACKGROUND: Recombinant human acid α-glucosidase (rhGAA) enzyme replacement therapy (ERT) has prolonged survival in infantile Pompe disease (IPD), but has unmasked central nervous system (CNS) changes. METHODS: Brain imaging, consisting of computed tomography (CT) and/or magnetic resonance imaging (MRI), was performed on 23 patients with IPD (17 CRIM-positive, 6 CRIM-negative) aged 2-38months. Most patients had baseline neuroimaging performed prior to the initiation of ERT. Follow-up neuroimaging was performed in eight. RESULTS: Sixteen patients (70%) had neuroimaging abnormalities consisting of ventricular enlargement (VE) and/or extra-axial cerebrospinal fluid accumulation (EACSF) at baseline, with delayed myelination in two. Follow-up neuroimaging (n=8) after 6-153months showed marked improvement, with normalization of VE and EACSF in seven patients. Two of three patients imaged after age 10years demonstrated white matter changes, with one noted to have a basilar artery aneurysm. CONCLUSIONS: Mild abnormalities on brain imaging in untreated or newly treated patients with IPD tend to resolve with time, in conjunction with ERT. However, white matter changes are emerging as seen in Patients 1 and 3 which included abnormal periventricular white matter changes with subtle signal abnormalities in the basal ganglia and minimal, symmetric signal abnormalities involving the deep frontoparietal cerebral white matter, respectively. The role of neuroimaging as part of the clinical evaluation of IPD needs to be considered to assess for white matter changes and cerebral aneurysms.
Authors: B J Ebbink; F K Aarsen; C M van Gelder; J M P van den Hout; N Weisglas-Kuperus; J Jaeken; M H Lequin; W F M Arts; A T van der Ploeg Journal: Neurology Date: 2012-04-25 Impact factor: 9.910
Authors: Gail A Spiridigliozzi; James H Heller; Laura E Case; Harrison N Jones; Priya S Kishnani Journal: Mol Genet Metab Date: 2011-10-28 Impact factor: 4.797
Authors: P S Kishnani; D Corzo; M Nicolino; B Byrne; H Mandel; W L Hwu; N Leslie; J Levine; C Spencer; M McDonald; J Li; J Dumontier; M Halberthal; Y H Chien; R Hopkin; S Vijayaraghavan; D Gruskin; D Bartholomew; A van der Ploeg; J P Clancy; R Parini; G Morin; M Beck; G S De la Gastine; M Jokic; B Thurberg; S Richards; D Bali; M Davison; M A Worden; Y T Chen; J E Wraith Journal: Neurology Date: 2006-12-06 Impact factor: 9.910
Authors: Richard J Ing; D Ryan Cook; Resai A Bengur; Eric A Williams; John Eck; Guy de L Dear; Allison K Ross; Frank H Kern; Priya S Kishnani Journal: Paediatr Anaesth Date: 2004-06 Impact factor: 2.556
Authors: Su Xu; Yi Lun; Michelle Frascella; Anadina Garcia; Rebecca Soska; Anju Nair; Abdul S Ponery; Adriane Schilling; Jessie Feng; Steven Tuske; Maria Cecilia Della Valle; José A Martina; Evelyn Ralston; Russell Gotschall; Kenneth J Valenzano; Rosa Puertollano; Hung V Do; Nina Raben; Richie Khanna Journal: JCI Insight Date: 2019-03-07
Authors: Barry J Byrne; David D Fuller; Barbara K Smith; Nathalie Clement; Kirsten Coleman; Brian Cleaver; Lauren Vaught; Darin J Falk; Angela McCall; Manuela Corti Journal: Ann Transl Med Date: 2019-07
Authors: Manuela Corti; Cristina Liberati; Barbara K Smith; Lee Ann Lawson; Ibrahim S Tuna; Thomas J Conlon; Kirsten E Coleman; Saleem Islam; Roland W Herzog; David D Fuller; Shelley W Collins; Barry J Byrne Journal: Hum Gene Ther Clin Dev Date: 2017-12 Impact factor: 5.032
Authors: Aditi Korlimarla; Gail A Spiridigliozzi; Kelly Crisp; Mrudu Herbert; Steven Chen; Michael Malinzak; Mihaela Stefanescu; Stephanie L Austin; Heidi Cope; Kanecia Zimmerman; Harrison Jones; James M Provenzale; Priya S Kishnani Journal: Neurology Date: 2020-06-09 Impact factor: 9.910
Authors: Rossella Parini; Paola De Lorenzo; Andrea Dardis; Alberto Burlina; Alessandra Cassio; Paolo Cavarzere; Daniela Concolino; Roberto Della Casa; Federica Deodato; Maria Alice Donati; Agata Fiumara; Serena Gasperini; Francesca Menni; Veronica Pagliardini; Michele Sacchini; Marco Spada; Roberta Taurisano; Maria Grazia Valsecchi; Maja Di Rocco; Bruno Bembi Journal: Orphanet J Rare Dis Date: 2018-02-08 Impact factor: 4.123
Authors: Anna F Fusco; Angela L McCall; Justin S Dhindsa; Lucy Zheng; Aidan Bailey; Amanda F Kahn; Mai K ElMallah Journal: Int J Mol Sci Date: 2020-03-24 Impact factor: 5.923